NIH And 10 Biopharmas Hatch Plan To Accelerate And Improve Therapeutic Pathway Research
This article was originally published in The Pink Sheet Daily
Executive Summary
With $230 million from industry and NIH, the Accelerating Medicines Partnership will seek to hasten and improve the success rate for discovery of biomarkers and therapeutic pathways in Alzheimer’s, type 2 diabetes, rheumatoid arthritis and lupus.